India Approves Two COVID Vaccines for Children Under 12

By Reuters Staff

April 27, 2022

BENGALURU (Reuters) - India has approved emergency use of Biological E's COVID-19 vaccine Corbevax for children aged five to 12 and Bharat Biotech's Covaxin inactivated-virus vaccine for six to 12-year olds, the country's health minister said in a tweet on Tuesday.

Corbevax, a recombinant protein subunit vaccine, was developed by researchers at the Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine, along with Dynavax, of Emeryville, California, whose CpG 1018 adjuvant is part of the design.